As the global population ages, older adults with atherosclerotic cardiovascular disease (ASCVD) are projected to drive a ...
Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results